Quest Diagnostics (DGX) EBT (2009 - 2026)

Quest Diagnostics has disclosed EBT across 18 years of filings, most recently posting $412.0 million for Q2 2026.

• In Q2 2026, EBT rose 7.29% year-over-year to $412.0 million; the TTM figure through Jun 2026 stood at $1.4 billion (up 11.87% YoY), while the FY2025 annual figure was $1.3 billion, up 12.17% from the prior year.
• EBT came in at $412.0 million for Q2 2026 at Quest Diagnostics, up from $334.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $452.0 million in Q1 2022 to a low of $109.0 million in Q4 2022.
• Average EBT over 5 years is $311.3 million, with a median of $315.5 million recorded in 2023.
• Year-over-year, EBT tumbled 78.29% in 2022 and jumped 117.43% in 2023.
• Over 5 years, EBT stood at $109.0 million in 2022, then jumped by 117.43% to $237.0 million in 2023, then climbed by 26.16% to $299.0 million in 2024, then advanced by 10.37% to $330.0 million in 2025, then increased by 24.85% to $412.0 million in 2026.
• Per Business Quant data, the three most recent EBT figures were $412.0 million in Q2 2026, $334.0 million in Q1 2026, and $330.0 million in Q4 2025.